APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hospital-Acquired Infections Assays

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Hospital-Acquired Infections Assays Industry Growth and Trends Forecast to 2032

4 March 2026100 pages

Choose your research edition.

Industry ResearchHospital-Acquired Infections Assays Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Hospital-Acquired Infections Assays Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Hospital-Acquired Infections Assays Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hospital-Acquired Infections Assays Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Hospital-Acquired Infections Assays Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

According to APO Research, the global Hospital-Acquired Infections Assays market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Hospital-Acquired Infections Assays is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Hospital-Acquired Infections Assays is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hospital-Acquired Infections Assays is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Hospital-Acquired Infections Assays market include BIOMÉRIEUX, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthcare Private Limited, BD (Becton, Dickinson and Company), Bioscience, Inc., QIAGEN, Thermo Fisher Scientific Inc. and Meridian Bioscience, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Hospital-Acquired Infections Assays market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hospital-Acquired Infections Assays market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hospital-Acquired Infections Assays market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hospital-Acquired Infections Assays.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Hospital-Acquired Infections Assays market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hospital-Acquired Infections Assays Market by Company

BIOMÉRIEUX

Abbott

F. Hoffmann-La Roche Ltd.

Siemens Healthcare Private Limited

BD (Becton, Dickinson and Company)

Bioscience, Inc.

QIAGEN

Thermo Fisher Scientific Inc.

Meridian Bioscience, Inc.

Hologic, Inc.

Hospital-Acquired Infections Assays Segment by Type

Blood Tests

Urinalysis

Hospital-Acquired Infections Assays Segment by Application

Urinary Tract Infections

Pneumonia

Surgical Site Infections

Bloodstream Infections

Other Hospital Infections

Hospital-Acquired Infections Assays Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hospital-Acquired Infections Assays market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hospital-Acquired Infections Assays and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hospital-Acquired Infections Assays.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Hospital-Acquired Infections Assays companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Hospital-Acquired Infections Assays Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Hospital-Acquired Infections Assays Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Hospital-Acquired Infections Assays Market Share by Region (2021-2026) Table 4. Global Hospital-Acquired Infections Assays Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Hospital-Acquired Infections Assays Market Share by Region (2027-2032) Table 6. Global Hospital-Acquired Infections Assays Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Hospital-Acquired Infections Assays Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Hospital-Acquired Infections Assays Market Size Share by Type (2021-2026) Table 9. Global Hospital-Acquired Infections Assays Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Hospital-Acquired Infections Assays Market Size Share Forecasted by Type (2027-2032) Table 11. North America Hospital-Acquired Infections Assays Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Hospital-Acquired Infections Assays Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Hospital-Acquired Infections Assays Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Hospital-Acquired Infections Assays Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Hospital-Acquired Infections Assays Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Hospital-Acquired Infections Assays Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Hospital-Acquired Infections Assays Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Hospital-Acquired Infections Assays Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Hospital-Acquired Infections Assays Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Hospital-Acquired Infections Assays Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Hospital-Acquired Infections Assays Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Hospital-Acquired Infections Assays Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Hospital-Acquired Infections Assays Market Size Share by Application (2021-2026) Table 24. Global Hospital-Acquired Infections Assays Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Hospital-Acquired Infections Assays Market Size Share Forecasted by Application (2027-2032) Table 26. North America Hospital-Acquired Infections Assays Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Hospital-Acquired Infections Assays Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Hospital-Acquired Infections Assays Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Hospital-Acquired Infections Assays Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Hospital-Acquired Infections Assays Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Hospital-Acquired Infections Assays Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Hospital-Acquired Infections Assays Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Hospital-Acquired Infections Assays Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Hospital-Acquired Infections Assays Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Hospital-Acquired Infections Assays Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Hospital-Acquired Infections Assays Industry Trends Table 37. Hospital-Acquired Infections Assays Industry Drivers Table 38. Hospital-Acquired Infections Assays Industry Opportunities and Challenges Table 39. Hospital-Acquired Infections Assays Industry Restraints Table 40. Global Hospital-Acquired Infections Assays Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Hospital-Acquired Infections Assays Revenue Market Share by Company (2021-2026) Table 42. Global Hospital-Acquired Infections Assays Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Hospital-Acquired Infections Assays Key Company Headquarters & Area Served Table 44. Global Hospital-Acquired Infections Assays Company, Product Type & Application Table 45. Global Hospital-Acquired Infections Assays Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Hospital-Acquired Infections Assays by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. BIOMÉRIEUX Company Information Table 49. BIOMÉRIEUX Business Overview Table 50. BIOMÉRIEUX Hospital-Acquired Infections Assays Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. BIOMÉRIEUX Hospital-Acquired Infections Assays Product Portfolio Table 52. BIOMÉRIEUX Recent Development Table 53. Abbott Company Information Table 54. Abbott Business Overview Table 55. Abbott Hospital-Acquired Infections Assays Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Abbott Hospital-Acquired Infections Assays Product Portfolio Table 57. Abbott Recent Development Table 58. F. Hoffmann-La Roche Ltd. Company Information Table 59. F. Hoffmann-La Roche Ltd. Business Overview Table 60. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product Portfolio Table 62. F. Hoffmann-La Roche Ltd. Recent Development Table 63. Siemens Healthcare Private Limited Company Information Table 64. Siemens Healthcare Private Limited Business Overview Table 65. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product Portfolio Table 67. Siemens Healthcare Private Limited Recent Development Table 68. BD (Becton, Dickinson and Company) Company Information Table 69. BD (Becton, Dickinson and Company) Business Overview Table 70. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product Portfolio Table 72. BD (Becton, Dickinson and Company) Recent Development Table 73. Bioscience, Inc. Company Information Table 74. Bioscience, Inc. Business Overview Table 75. Bioscience, Inc. Hospital-Acquired Infections Assays Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Bioscience, Inc. Hospital-Acquired Infections Assays Product Portfolio Table 77. Bioscience, Inc. Recent Development Table 78. QIAGEN Company Information Table 79. QIAGEN Business Overview Table 80. QIAGEN Hospital-Acquired Infections Assays Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. QIAGEN Hospital-Acquired Infections Assays Product Portfolio Table 82. QIAGEN Recent Development Table 83. Thermo Fisher Scientific Inc. Company Information Table 84. Thermo Fisher Scientific Inc. Business Overview Table 85. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product Portfolio Table 87. Thermo Fisher Scientific Inc. Recent Development Table 88. Meridian Bioscience, Inc. Company Information Table 89. Meridian Bioscience, Inc. Business Overview Table 90. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product Portfolio Table 92. Meridian Bioscience, Inc. Recent Development Table 93. Hologic, Inc. Company Information Table 94. Hologic, Inc. Business Overview Table 95. Hologic, Inc. Hospital-Acquired Infections Assays Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Hologic, Inc. Hospital-Acquired Infections Assays Product Portfolio Table 97. Hologic, Inc. Recent Development Table 98. North America Hospital-Acquired Infections Assays Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Hospital-Acquired Infections Assays Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Hospital-Acquired Infections Assays Market Share by Country (2021-2026) Table 101. North America Hospital-Acquired Infections Assays Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Hospital-Acquired Infections Assays Market Share Forecast by Country (2027-2032) Table 103. Europe Hospital-Acquired Infections Assays Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Hospital-Acquired Infections Assays Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Hospital-Acquired Infections Assays Market Share by Country (2021-2026) Table 106. Europe Hospital-Acquired Infections Assays Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Hospital-Acquired Infections Assays Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Hospital-Acquired Infections Assays Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Hospital-Acquired Infections Assays Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Hospital-Acquired Infections Assays Market Share by Country (2021-2026) Table 111. Asia-Pacific Hospital-Acquired Infections Assays Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Hospital-Acquired Infections Assays Market Share Forecast by Country (2027-2032) Table 113. Latin America Hospital-Acquired Infections Assays Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America Hospital-Acquired Infections Assays Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America Hospital-Acquired Infections Assays Market Share by Country (2021-2026) Table 116. Latin America Hospital-Acquired Infections Assays Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America Hospital-Acquired Infections Assays Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa Hospital-Acquired Infections Assays Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa Hospital-Acquired Infections Assays Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa Hospital-Acquired Infections Assays Market Share by Country (2021-2026) Table 121. Middle East & Africa Hospital-Acquired Infections Assays Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa Hospital-Acquired Infections Assays Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Hospital-Acquired Infections Assays Product Image Figure 3. Global Hospital-Acquired Infections Assays Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 5. Global Hospital-Acquired Infections Assays Market Share by Region: 2025 VS 2032 Figure 6. Global Hospital-Acquired Infections Assays Market Share by Region (2021-2032) Figure 7. North America Hospital-Acquired Infections Assays Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Hospital-Acquired Infections Assays Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Hospital-Acquired Infections Assays Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Hospital-Acquired Infections Assays Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Hospital-Acquired Infections Assays Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Blood Tests Image Figure 13. Global Blood Tests Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Urinalysis Image Figure 15. Global Urinalysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Hospital-Acquired Infections Assays Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Hospital-Acquired Infections Assays Market Share by Type 2025 VS 2032 Figure 18. North America Hospital-Acquired Infections Assays Market Size Share by Type (2021-2032) Figure 19. Europe Hospital-Acquired Infections Assays Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Hospital-Acquired Infections Assays Market Size Share by Type (2021-2032) Figure 21. Latin America Hospital-Acquired Infections Assays Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Hospital-Acquired Infections Assays Market Size Share by Type (2021-2032) Figure 23. Urinary Tract Infections Image Figure 24. Global Urinary Tract Infections Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Pneumonia Image Figure 26. Global Pneumonia Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Surgical Site Infections Image Figure 28. Global Surgical Site Infections Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Bloodstream Infections Image Figure 30. Global Bloodstream Infections Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Other Hospital Infections Image Figure 32. Global Other Hospital Infections Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Hospital-Acquired Infections Assays Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Hospital-Acquired Infections Assays Market Share by Application 2025 VS 2032 Figure 35. North America Hospital-Acquired Infections Assays Market Size Share by Application (2021-2032) Figure 36. Europe Hospital-Acquired Infections Assays Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Hospital-Acquired Infections Assays Market Size Share by Application (2021-2032) Figure 38. Latin America Hospital-Acquired Infections Assays Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Hospital-Acquired Infections Assays Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Hospital-Acquired Infections Assays Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Hospital-Acquired Infections Assays Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Hospital-Acquired Infections Assays Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Hospital-Acquired Infections Assays Market Share by Country (2021-2032) Figure 45. Europe Hospital-Acquired Infections Assays Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Hospital-Acquired Infections Assays Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Hospital-Acquired Infections Assays Market Share by Country (2021-2032) Figure 48. Asia-Pacific Hospital-Acquired Infections Assays Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Hospital-Acquired Infections Assays Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Hospital-Acquired Infections Assays Market Share by Country (2021-2032) Figure 51. Latin America Hospital-Acquired Infections Assays Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Hospital-Acquired Infections Assays Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Hospital-Acquired Infections Assays Market Share by Country (2021-2032) Figure 54. Middle East & Africa Hospital-Acquired Infections Assays Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Hospital-Acquired Infections Assays Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Hospital-Acquired Infections Assays Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Tests
  • Urinalysis
Applications
  • Urinary Tract Infections
  • Pneumonia
  • Surgical Site Infections
  • Bloodstream Infections
  • Other Hospital Infections
Companies covered
  • BIOMÉRIEUX
  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare Private Limited
  • BD (Becton, Dickinson and Company)
  • Bioscience, Inc.
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Meridian Bioscience, Inc.
  • Hologic, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Hospital-Acquired Infections Assays Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Hospital-Acquired Infections Assays Market Size by Region (2021-2032)
  5. 1.4.1 Global Hospital-Acquired Infections Assays Market Size by Region (2021-2026)
  6. 1.4.2 Global Hospital-Acquired Infections Assays Market Size by Region (2027-2032)
  7. 1.5 Key Regions Hospital-Acquired Infections Assays Market Size (2021-2032)
  8. 1.5.1 North America Hospital-Acquired Infections Assays Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Hospital-Acquired Infections Assays Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Hospital-Acquired Infections Assays Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Hospital-Acquired Infections Assays Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Hospital-Acquired Infections Assays Market Size Growth Rate (2021-2032)
2 Hospital-Acquired Infections Assays Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Blood Tests
  3. 2.1.2 Urinalysis
  4. 2.2 Global Hospital-Acquired Infections Assays Market Size by Type
  5. 2.2.1 Global Hospital-Acquired Infections Assays Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Hospital-Acquired Infections Assays Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Hospital-Acquired Infections Assays Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Hospital-Acquired Infections Assays Market Size by Regions
  9. 2.3.1 North America Hospital-Acquired Infections Assays Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Hospital-Acquired Infections Assays Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Hospital-Acquired Infections Assays Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Hospital-Acquired Infections Assays Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Hospital-Acquired Infections Assays Market Size Breakdown by Type (2021-2026)
3 Hospital-Acquired Infections Assays Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Urinary Tract Infections
  3. 3.1.2 Pneumonia
  4. 3.1.3 Surgical Site Infections
  5. 3.1.4 Bloodstream Infections
  6. 3.1.5 Other Hospital Infections
  7. 3.2 Global Hospital-Acquired Infections Assays Market Size by Application
  8. 3.2.1 Global Hospital-Acquired Infections Assays Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Hospital-Acquired Infections Assays Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Hospital-Acquired Infections Assays Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Hospital-Acquired Infections Assays Market Size by Regions
  12. 3.3.1 North America Hospital-Acquired Infections Assays Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Hospital-Acquired Infections Assays Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Hospital-Acquired Infections Assays Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Hospital-Acquired Infections Assays Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Hospital-Acquired Infections Assays Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Hospital-Acquired Infections Assays Industry Trends
  2. 4.2 Hospital-Acquired Infections Assays Industry Drivers
  3. 4.3 Hospital-Acquired Infections Assays Industry Opportunities and Challenges
  4. 4.4 Hospital-Acquired Infections Assays Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Hospital-Acquired Infections Assays Revenue (2021-2026)
  2. 5.2 Global Hospital-Acquired Infections Assays Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Hospital-Acquired Infections Assays Key Company Headquarters & Area Served
  4. 5.4 Global Hospital-Acquired Infections Assays Company, Product Type & Application
  5. 5.5 Global Hospital-Acquired Infections Assays Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Hospital-Acquired Infections Assays Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Hospital-Acquired Infections Assays Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Hospital-Acquired Infections Assays Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 BIOMÉRIEUX
  2. 6.1.1 BIOMÉRIEUX Company Information
  3. 6.1.2 BIOMÉRIEUX Business Overview
  4. 6.1.3 BIOMÉRIEUX Hospital-Acquired Infections Assays Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 BIOMÉRIEUX Hospital-Acquired Infections Assays Product Portfolio
  6. 6.1.5 BIOMÉRIEUX Recent Developments
  7. 6.2 Abbott
  8. 6.2.1 Abbott Company Information
  9. 6.2.2 Abbott Business Overview
  10. 6.2.3 Abbott Hospital-Acquired Infections Assays Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Abbott Hospital-Acquired Infections Assays Product Portfolio
  12. 6.2.5 Abbott Recent Developments
  13. 6.3 F. Hoffmann-La Roche Ltd.
  14. 6.3.1 F. Hoffmann-La Roche Ltd. Company Information
  15. 6.3.2 F. Hoffmann-La Roche Ltd. Business Overview
  16. 6.3.3 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product Portfolio
  18. 6.3.5 F. Hoffmann-La Roche Ltd. Recent Developments
  19. 6.4 Siemens Healthcare Private Limited
  20. 6.4.1 Siemens Healthcare Private Limited Company Information
  21. 6.4.2 Siemens Healthcare Private Limited Business Overview
  22. 6.4.3 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product Portfolio
  24. 6.4.5 Siemens Healthcare Private Limited Recent Developments
  25. 6.5 BD (Becton, Dickinson and Company)
  26. 6.5.1 BD (Becton, Dickinson and Company) Company Information
  27. 6.5.2 BD (Becton, Dickinson and Company) Business Overview
  28. 6.5.3 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product Portfolio
  30. 6.5.5 BD (Becton, Dickinson and Company) Recent Developments
  31. 6.6 Bioscience, Inc.
  32. 6.6.1 Bioscience, Inc. Company Information
  33. 6.6.2 Bioscience, Inc. Business Overview
  34. 6.6.3 Bioscience, Inc. Hospital-Acquired Infections Assays Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Bioscience, Inc. Hospital-Acquired Infections Assays Product Portfolio
  36. 6.6.5 Bioscience, Inc. Recent Developments
  37. 6.7 QIAGEN
  38. 6.7.1 QIAGEN Company Information
  39. 6.7.2 QIAGEN Business Overview
  40. 6.7.3 QIAGEN Hospital-Acquired Infections Assays Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 QIAGEN Hospital-Acquired Infections Assays Product Portfolio
  42. 6.7.5 QIAGEN Recent Developments
  43. 6.8 Thermo Fisher Scientific Inc.
  44. 6.8.1 Thermo Fisher Scientific Inc. Company Information
  45. 6.8.2 Thermo Fisher Scientific Inc. Business Overview
  46. 6.8.3 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product Portfolio
  48. 6.8.5 Thermo Fisher Scientific Inc. Recent Developments
  49. 6.9 Meridian Bioscience, Inc.
  50. 6.9.1 Meridian Bioscience, Inc. Company Information
  51. 6.9.2 Meridian Bioscience, Inc. Business Overview
  52. 6.9.3 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product Portfolio
  54. 6.9.5 Meridian Bioscience, Inc. Recent Developments
  55. 6.10 Hologic, Inc.
  56. 6.10.1 Hologic, Inc. Company Information
  57. 6.10.2 Hologic, Inc. Business Overview
  58. 6.10.3 Hologic, Inc. Hospital-Acquired Infections Assays Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Hologic, Inc. Hospital-Acquired Infections Assays Product Portfolio
  60. 6.10.5 Hologic, Inc. Recent Developments
7 North America
  1. 7.1 North America Hospital-Acquired Infections Assays Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Hospital-Acquired Infections Assays Market Size by Country (2021-2026)
  3. 7.3 North America Hospital-Acquired Infections Assays Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Hospital-Acquired Infections Assays Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Hospital-Acquired Infections Assays Market Size by Country (2021-2026)
  3. 8.3 Europe Hospital-Acquired Infections Assays Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Hospital-Acquired Infections Assays Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Hospital-Acquired Infections Assays Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Hospital-Acquired Infections Assays Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Hospital-Acquired Infections Assays Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Hospital-Acquired Infections Assays Market Size by Country (2021-2026)
  3. 10.3 South America Hospital-Acquired Infections Assays Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Hospital-Acquired Infections Assays Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Hospital-Acquired Infections Assays Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Hospital-Acquired Infections Assays Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst